As all providers know, healthcare is one of the most heavily regulated industries in the United States. Unfortunately, failure to abide by these regulations may have far more wide-reaching impacts on a physician and a physician’s practice than... Read More
Responding to the American Medical Association’s July 2018 “Truth in Advertising” campaign, the New Jersey legislature articulated a compelling State interest in: “patients being promptly and clearly informed of the training and... Read More
In November 2020, the U.S. Department of Health & Human Services, Office of Inspector General (the “OIG”) issued a Special Fraud Alert to highlight the fraud and abuse risks associated with pharmaceutical and medical device company speaker... Read More
Frier Levitt Co-Founding Partner Daniel B. Frier recently summarized a variety of ways in which providers can become ensnarled in fraudulent schemes disguised as legitimate business models. Since the publication of that article, a significant... Read More
On April 1, 2020, Governor Phil Murphy signed Executive Order 112, authorizing the Director of Consumer Affairs (“Director”) to reactivate the licenses of recently retired health care professionals temporarily. The Executive Order applies to... Read More
The current Coronavirus (COVID-19) Pandemic is having enormous impacts on healthcare providers as they and their employees staff the front lines during this crisis. From dealing with unbelievable shortages in staffing, to making protective... Read More
Recently Frier Levitt defended three medical professionals facing patient allegations. These New Jersey physicians: an orthopedic surgeon, a pulmonologist, and a hematologist & oncologist were due to face before the Board of Medical Examiners as... Read More
